Acupoint stimulation therapy is shown to improve palpitations, dyspnea, cognitive impairment, anxiety, depression, and other symptoms in PASC patients 765
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders GLP1 agonist drugs transformed the weight loss and diabetes landscape in 2023, propelled by robust clinical trial results and a surge in endorsements from celebrities and influencers
Systemic side effects are uncommon but may include brief headache or lightheadedness
Carlsen, E., Giwercman, A., Keiding, N
All current findings remain pre-clinical and exploratory , with ongoing studies aimed at better understanding L-Carnitines role as a research tool for cellular energy transport and metabolic signaling analysis
PMID: 23 KulkarniSDurhamHGloverLAtherOPhillipsVNemesSet al